Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IceCure Medical Ltd. (ICCM : NSDQ)
 
 • Company Description   
IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel.

Number of Employees: 64

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.95 Daily Weekly Monthly
20 Day Moving Average: 24,577 shares
Shares Outstanding: (millions)
Market Capitalization: $ (millions)
Beta:
52 Week High: $13.20
52 Week Low: $1.68
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -12.56% -8.05%
12 Week -23.83% -16.02%
Year To Date -36.07% -23.41%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7 HA? ESHEL STREET PO BOX 3163
-
CAESAREA,L3 3079504
ISR
ph: 972-4623-0333
fax: 972-4623-0222
jeremy@lifesciadvisors.com http://www.icecure-medical.com
 
 • General Corporate Information   
Officers
Eyal Shamir - Chief Executive Officer
Ron Mayron - Chairman of the Board of Directors
Ronen Tsimerman - Chief Operation Officer;Chief Financial Officer
Shay Levav - Vice President
Tlalit Bussi Tel-Tzure - Vice President

Peer Information
IceCure Medical Ltd. (CHCR)
IceCure Medical Ltd. (ESRX)
IceCure Medical Ltd. (MYDP)
IceCure Medical Ltd. (GBCS)
IceCure Medical Ltd. (LAXAF)
IceCure Medical Ltd. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: M53071136
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/17/22
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta:
Market Capitalization: $ (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.27 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/17/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -20.00%
Sales Growth
vs. Year Ago Period: -47.98%
vs. Previous Quarter: -44.83%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -
12/31/21 - -
09/30/21 - -
Current Ratio
03/31/22 - 5.40
12/31/21 - 7.54
09/30/21 - 3.92
Quick Ratio
03/31/22 - 4.93
12/31/21 - 7.06
09/30/21 - 3.53
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -239.13
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - -
09/30/21 - -
Inventory Turnover
03/31/22 - -
12/31/21 - 1.50
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.03
12/31/21 - 0.03
09/30/21 - 0.06
Debt-to-Capital
03/31/22 - 2.62
12/31/21 - 2.48
09/30/21 - 5.58
 

Powered by Zacks Investment Research ©